Edgen Stock·Sep 30 2025, 10:51戻る
戻る
Apellis Pharmaceuticals Reports Mixed Q2 Results Amidst Key FDA Approval
Edgen Stock·Sep 30 2025, 10:51
[1] Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) (https://finance.yahoo.com/news/wall-street-mi ...)[2] Wall Street Has a Mixed Opinion on Apellis Pharmaceuticals (APLS) - Insider Monkey (https://vertexaisearch.cloud.google.com/groun ...)[3] Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results - Stock Titan (https://vertexaisearch.cloud.google.com/groun ...)